Detalles de la búsqueda
1.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
J Autoimmun
; 125: 102744, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781162
2.
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional study.
Minerva Endocrinol (Torino)
; 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38576377
3.
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Curr Pharm Des
; 28(24): 2022-2028, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35726427
4.
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
Curr Pharm Des
; 27(41): 4245-4252, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477509
5.
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Clin Rheumatol
; 39(11): 3195-3204, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852623
6.
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
PLoS One
; 13(10): e0205134, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356301
Resultados
1 -
6
de 6
1
Próxima >
>>